ICP-B794

· Beijing InnoCare Pharma Tech Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ICP-B794, covering 2025-08-22 to 2025-08-22. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of ICP-B794 in Patients With Advanced Solid Tumors [Phase 1]